Blockchain Registration Transaction Record

GeoVax Labs CEO to Present at 37th Annual Roth Conference on Immunotherapies and Vaccines

GeoVax Labs CEO David Dodd to present at 37th Annual Roth Conference on March 17, 2025, showcasing the company's innovative immunotherapies and vaccines. Learn about GeoVax's lead clinical program for a COVID-19 vaccine and its impact on the biotechnology industry.

GeoVax Labs CEO to Present at 37th Annual Roth Conference on Immunotherapies and Vaccines

This news highlights GeoVax's advancements in developing vaccines against infectious diseases and cancers, including a next-generation COVID-19 vaccine. Investors and stakeholders in the biotechnology and healthcare industries should pay attention to GeoVax's presentation at the conference.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x1e6b896265821bc1e237cc9804c84b781a915b43786db9dd24631015397a31a6
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintrift0wWM-25e9e086bc17686363c32336fea5eb50